Milestone Pharmaceutiques IncNovember 19, 2024

FDA 483 - Milestone Pharmaceutiques Inc - November 19, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Milestone Pharmaceutiques Inc

Record Details

Milestone Pharmaceuticals Inc. in Saint-Laurent was inspected by the FDA from November 11-19, 2024. The inspection identified a failure by the firm to notify the FDA about the for-cause termination of a clinical investigator from a study. This observation highlights a lapse in regulatory reporting requirements for clinical trials.

Company: Milestone Pharmaceutiques Inc
Inspection Date: November 19, 2024
Product Type: Drugs
Office: Office of Inspections and Investigations
Person: David L. Chon (Consumer Safety Officer/BIMO Investigator)

Open in Dashboard

ID · 14b2ec40-b625-45cb-99a3-051369423430